September 8, 2022 – Vancouver, British Columbia – Further to its press releases dated June 7, 2022 and September 6, 2022, Delivra Health Brands Inc. ("Delivra Health" or the "Company") (TSX-V: DHB; OTCQB: DHBUF), formerly, Harvest One Cannabis Inc. (TSX-V: HVT; OTCQB: HRVOF), a consumer packaged goods leader uniquely positioned in both the OTC non-infused and licensed cannabis-infused segments with a focus on health and wellness products, is pleased to announce that effective today, the Company’s name has changed from “Harvest One Cannabis Inc.” to “Delivra Health Brands Inc.” (the “Name Change”). The TSX Venture Exchange (the “TSXV”) has granted final approval for the Name Change.

“Delivra Health is pioneering the future of alternative health and wellness products and working to enhance quality of life worldwide. Delivra Health products feature innovative brands like Dream Water™ and LivRelief™ which deliver relief from everyday health struggles, such as chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. We are grateful to have loyal brand champions today in over 20 countries,” said Gord Davey, President and Chief Executive Officer of Delivra Health.

The Company’s new corporate website, www.delivrahealthbrands.com, contains information about the Company and its go-forward strategy. The Company’s archived historical corporate information, including financial results and news releases, will also be available on the new website.

The new CUSIP / ISIN for the common shares of the Company (the “Common Shares”) will be 24703H102 / CA24703H1029. The new CUSIP / ISIN for the warrants of the Company issued under a warrant indenture dated March 17, 2021 (the “Warrants”) will be 24703H110 / CA24703H1102. Effective today, the Common Shares will trade under the symbol "DHB", and the Warrants will trade under the symbol "DHB.WT" on the TSXV.

About Delivra Health Brands Inc.

Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! Our Delivra Health portfolio features innovative brands like Dream Water™ and LivRelief™ that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company’s two subsidiaries are Dream Water™ and LivRelief ^TM. For more information, please visit www.delivrahealthbrands.com.

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the Company pioneering the future of alternative health and wellness products, the Company enhancing quality of life, proposed benefits of the Company’s products, updates to the corporate website of the Company, and the future of the Company's health and wellness businesses and go-forward strategy.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company's operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward- looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's

management's discussion and analysis dated May 30, 2022, for the three and nine months ended March 31, 2022, filed under the Company's profile on SEDAR at www.sedar.com.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934